Canada Markets closed

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1250+0.0050 (+4.17%)
At close: 12:56PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 513.96M
Enterprise Value 316.05M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)6.88
Price/Book (mrq)N/A
Enterprise Value/Revenue 37.91
Enterprise Value/EBITDA 6-11.35

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.1800
52 Week Low 30.0650
50-Day Moving Average 30.1190
200-Day Moving Average 30.0978

Share Statistics

Avg Vol (3 month) 3165.76k
Avg Vol (10 day) 391.61k
Shares Outstanding 5111.69M
Float 100.55M
% Held by Insiders 18.86%
% Held by Institutions 18.02%
Shares Short (Aug. 30, 2020) 4366.74k
Short Ratio (Aug. 30, 2020) 40.41
Short % of Float (Aug. 30, 2020) 4N/A
Short % of Shares Outstanding (Aug. 30, 2020) 40.33%
Shares Short (prior month Jul. 30, 2020) 4597.27k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin -114.65%
Operating Margin (ttm)-77.98%

Management Effectiveness

Return on Assets (ttm)-44.11%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.03M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)36.70%
Gross Profit (ttm)1.63M
EBITDA -1.41M
Net Income Avi to Common (ttm)-2.33M
Diluted EPS (ttm)-0.0290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)324.77k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.41M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.88
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-983.02k
Levered Free Cash Flow (ttm)-733.44k